ASP Isotopes CEO Paul Mann Reveals 2026 Growth Plan, Nuclear Fuel, Semiconductors & U.S. Expansion
Apr. 1, 2026
Why are investors watching ASP Isotopes (Nasdaq: ASPI)?
In our investor overview, CEO Paul Mann explains how ASP Isotopes is building a business at the center of several high-value markets, including nuclear medicine, next-generation nuclear fuel, semiconductors, superconducting materials, and critical supply chains.
ASPI has built three manufacturing plants in South Africa and expects those facilities to turn commercial during 2026. The Company is also focused on expanding into the United States to help secure a supply of critical materials historically sourced from Russia. The broader ASPI investor story includes commercial progress in Silicon-28, Carbon-14/12, and Ytterbium-176, as well as strategic relationships with TerraPower and Fermi America.
